{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:15:58Z","timestamp":1761920158966,"version":"3.40.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jns.2016.06.030","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T23:08:38Z","timestamp":1466291318000},"page":"209-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1484-2968","authenticated-orcid":false,"given":"Jin Myoung","family":"Seok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Lim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.06.030_bb0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2016.06.030_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2016.06.030_bb0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":"A secondary progressive clinical course is uncommon in neuromyelitis optica","volume":"68","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.06.030_bb0020","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.06.030_bb0025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/01.wnl.0000234031.30756.a0","article-title":"Are initial demyelinating event recovery and time to second event under differential control?","volume":"67","author":"West","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.06.030_bb0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/01.wnl.0000342458.39625.91","article-title":"Demyelinating events in early multiple sclerosis have inherent severity and recovery","volume":"72","author":"Mowry","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.06.030_bb0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/jnnp.2008.157305","article-title":"The onset location of multiple sclerosis predicts the location of subsequent relapses","volume":"80","author":"Mowry","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.06.030_bb0040","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0b013e31821e559d","article-title":"Demographic and clinical characteristics of malignant multiple sclerosis","volume":"76","author":"Gholipour","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.06.030_bb0045","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1177\/1352458514528763","article-title":"The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses","volume":"20","author":"Zandona","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.06.030_bb0050","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.06.030_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3343\/alm.2012.32.5.331","article-title":"Clinical usefulness of cell-based indirect immunofluorescence assay for the detection of aquaporin-4 antibodies in neuromyelitis optica spectrum disorder","volume":"32","author":"Kang","year":"2012","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.jns.2016.06.030_bb0060","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.06.030_bb0065","article-title":"Benign neuromyelitis optica is rare in Japanese patients","author":"Uzawa","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.06.030_bb0070","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archneurol.2011.127","article-title":"A benign form of neuromyelitis optica: does it exist?","volume":"68","author":"Collongues","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.06.030_bb0075","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/WNO.0b013e318238937f","article-title":"Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection","volume":"31","author":"Sakai","year":"2011","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jns.2016.06.030_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2015.05.011","article-title":"Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease","author":"Murchison","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.06.030_bb0085","article-title":"Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica","author":"Masuda","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2016.06.030_bb0090","article-title":"Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange","author":"Abboud","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.06.030_bb0095","article-title":"Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints","author":"Jeong","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.06.030_bb0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jnnp-2013-306541","article-title":"Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials","volume":"85","author":"Kitley","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.06.030_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.2011.241760","article-title":"CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse","volume":"83","author":"Uzawa","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.06.030_bb0110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16303604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16303604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:25:57Z","timestamp":1536625557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16303604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":22,"alternative-id":["S0022510X16303604"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.06.030","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of disabling attacks at onset in patients with neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}